{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:45:56Z","timestamp":1782225956744,"version":"3.54.5"},"reference-count":26,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3530,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Paediatrica"],"published-print":{"date-parts":[[2006,1,1]]},"DOI":"10.1080\/08035250500275022","type":"journal-article","created":{"date-parts":[[2005,11,8]],"date-time":"2005-11-08T19:55:17Z","timestamp":1131479717000},"page":"86-92","source":"Crossref","is-referenced-by-count":127,"title":["Clinical manifestations of Fabry disease in children: Data from the Fabry Outcome Survey"],"prefix":"10.1111","volume":"95","author":[{"given":"Uma","family":"Ramaswami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Whybra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Parini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillem","family":"Pintos-Morell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gere","family":"Sunder-Plassmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Widmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ON","family":"BEHALF OF THE FOS EUROPEAN INVESTIG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"E00001","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","volume":"34","author":"Mehta A","year":"2004","unstructured":"Mehta, A and Ricci, R and Widmer, U and Dehout, F and Garcia de Lorenzo, A and Kampmann, C and (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey <i>Eur J Clin Invest<\/i>, 34, pp. 236 - 42.","journal-title":"Eur J Clin Invest"},{"key":"E00002","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.CIR.54.5.818","volume":"54","author":"Desnick RJ","year":"1976","unstructured":"Desnick, RJ and Blieden, LC and Sharp, HL and Hofschire, PJ and Moller, JH. (1976) Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies <i>Circulation<\/i>, 54, pp. 818 - 25.","journal-title":"Circulation"},{"key":"E00003","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ana.410040610","volume":"4","author":"Bird TD","year":"1978","unstructured":"Bird, TD and Lagunoff, D. (1978) Neurological manifestations of Fabry disease in female carriers <i>Ann Neurol<\/i>, 4, pp. 537 - 40.","journal-title":"Ann Neurol"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1023\/A:1012499119196","volume":"24","author":"Schiffmann R","year":"2001","unstructured":"Schiffmann, R. (2001) Natural history of Fabry disease in males: preliminary observations <i>J Inherit Metab Dis<\/i>, 24(Suppl 2), pp. 15 - 7.","journal-title":"J Inherit Metab Dis"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000060195","volume":"136","author":"Wendrich K","year":"2001","unstructured":"Wendrich, K and Whybra, C and Ries, M and Gal, A and Beck, M. (2001) Neurological manifestation of Fabry disease in females <i>Contrib Nephrol<\/i>, 136, pp. 241 - 4.","journal-title":"Contrib Nephrol"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1097\/01.ASN.0000016683.73778.78","volume":"13","author":"Branton MR","year":"2002","unstructured":"Branton, MR and Schiffmann, R and Kopp, JB. (2002) Natural history and treatment of renal involvement in Fabry disease <i>J Am Soc Nephrol<\/i>, 13(Suppl 2), pp. S139 - 43.","journal-title":"J Am Soc Nephrol"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1651-2227.2002.tb03105.x","volume":"Suppl 439","author":"Kampmann C","year":"2002","unstructured":"Kampmann, C and Wiethoff, CM and Martin, C and Wenzel, A and Kampmann, R and Whybra, C and (2002) Electrocardiographic signs of hypertrophy in Fabry disease-associated hypertrophic cardiomyopathy <i>Acta Paediatr<\/i>, Suppl 439, pp. 21 - 7.","journal-title":"Acta Paediatr"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1651-2227.2002.tb03104.x","volume":"Suppl 439","author":"Linhart A","year":"2002","unstructured":"Linhart, A and Magage, S and Palecek, T and Bultas, J. (2002) Cardiac involvement in Fabry disease <i>Acta Paediatr<\/i>, Suppl 439, pp. 15 - 20.","journal-title":"Acta Paediatr"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00128071-200304030-00005","volume":"4","author":"Mohrenschlager M","year":"2003","unstructured":"Mohrenschlager, M and Braun-Falco, M and Ring, J and Abeck, D. (2003) Fabry disease: recognition and management of cutaneous manifestations <i>Am J Clin Dermatol<\/i>, 4, pp. 189 - 96.","journal-title":"Am J Clin Dermatol"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/archderm.140.12.1440","volume":"140","author":"Larralde M","year":"2004","unstructured":"Larralde, M and Boggio, P and Amartino, H and Chamoles, N. (2004) Fabry disease: a study of 6 hemizygous men and 5 heterozygous women with emphasis on dermatologic manifestations <i>Arch Dermatol<\/i>, 140, pp. 1526 - 8.","journal-title":"Arch Dermatol"},{"key":"E00011","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","volume":"38","author":"MacDermot KD","year":"2001","unstructured":"MacDermot, KD and Holmes, A and Miners, AH. (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males <i>J Med Genet<\/i>, 38, pp. 750 - 60.","journal-title":"J Med Genet"},{"key":"E00012","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1012447102358","volume":"24","author":"MacDermot KD","year":"2001","unstructured":"MacDermot, KD and Holmes, A and Miners, AH. (2001) Natural history of Fabry disease in affected males and obligate carrier females <i>J Inherit Metab Dis<\/i>, 24(Suppl 2), pp. 13 - 4.","journal-title":"J Inherit Metab Dis"},{"key":"E00013","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","volume":"38","author":"MacDermot KD","year":"2001","unstructured":"MacDermot, KD and Holmes, A and Miners, AH. (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females <i>J Med Genet<\/i>, 38, pp. 769 - 75.","journal-title":"J Med Genet"},{"key":"E00014","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1651-2227.2002.tb03120.x","volume":"Suppl 439","author":"Lyon MF","year":"2002","unstructured":"Lyon, MF. (2002) X-chromosome inactivation and human genetic disease <i>Acta Paediatr<\/i>, Suppl 439, pp. 107 - 12.","journal-title":"Acta Paediatr"},{"key":"E00015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/jmg.2004.025791","volume":"42","author":"Hoffmann B","year":"2005","unstructured":"Hoffmann, B and Garcia de Lorenzo, A and Mehta, A and Beck, M and Widmer, U and Ricci, R. (2005) Effects of enzyme replacement therapy on pain and quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey) <i>J Med Genet<\/i>, 42, pp. 247 - 52.","journal-title":"J Med Genet"},{"key":"E00016","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","volume":"162","author":"Ries M","year":"2003","unstructured":"Ries, M and Ramaswami, U and Parini, R and Lindblad, B and Whybra, C and Willers, I and (2003) The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents <i>Eur J Pediatr<\/i>, 162, pp. 767 - 72.","journal-title":"Eur J Pediatr"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jpeds.2004.01.051","volume":"144","author":"Desnick RJ","year":"2004","unstructured":"Desnick, RJ and Brady, RO. (2004) Fabry disease in childhood <i>J Pediatr<\/i>, 144, pp. S20 - 6.","journal-title":"J Pediatr"},{"key":"E00018","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1542\/peds.2004-1678","volume":"115","author":"Ries M","year":"2005","unstructured":"Ries, M and Gupta, S and Moore, DF and Sachdev, V and Quirk, JM and Murray, GJ and (2005) Pediatric Fabry disease <i>Pediatrics<\/i>, 115, pp. e344 - 55.","journal-title":"Pediatrics"},{"key":"E00019","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","volume":"24","author":"Whybra C","year":"2001","unstructured":"Whybra, C and Kampmann, C and Willers, I and Davies, J and Winchester, B and Kriegsmann, J and (2001) Anderson\u2013Fabry disease: clinical manifestations of disease in female heterozygotes <i>J Inherit Metab Dis<\/i>, 24, pp. 715 - 24.","journal-title":"J Inherit Metab Dis"},{"key":"E00020","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0735-1097(02)02380-X","volume":"40","author":"Kampmann C","year":"2002","unstructured":"Kampmann, C and Baehner, F and Whybra, C and Martin, C and Wiethoff, CM and Ries, M and (2002) Cardiac manifestations of Anderson-Fabry disease in heterozygous females <i>J Am Coll Cardiol<\/i>, 40, pp. 1668 - 74.","journal-title":"J Am Coll Cardiol"},{"key":"E00021","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1445-5994.2002.00291.x","volume":"32","author":"Galanos J","year":"2002","unstructured":"Galanos, J and Nicholls, K and Grigg, L and Kiers, L and Crawford, A and Becker, G. (2002) Clinical features of Fabry's disease in Australian patients <i>Intern Med J<\/i>, 32, pp. 575 - 84.","journal-title":"Intern Med J"},{"key":"E00022","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/318809","volume":"68","author":"Eng CM","year":"2001","unstructured":"Eng, CM and Banikazemi, M and Gordon, RE and Goldman, M and Phelps, R and Kim, L and (2001) A phase 1\/2 clinical trial of enzyme replacement in Fabry disease: pharmacokinetic, substrate clearance, and safety studies <i>Am J Hum Genet<\/i>, 68, pp. 711 - 22.","journal-title":"Am J Hum Genet"},{"key":"E00023","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"Schiffmann R","year":"2001","unstructured":"Schiffmann, R and Kopp, JB and Austin, HA 3rd and Sabnis, S and Moore, DF and Weibel, T and (2001) Enzyme replacement therapy in Fabry disease: a randomized controlled trial <i>JAMA<\/i>, 285, pp. 2743 - 9.","journal-title":"JAMA"},{"key":"E00024","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/mus.10497","volume":"28","author":"Schiffmann R","year":"2003","unstructured":"Schiffmann, R and Floeter, MK and Dambrosia, JM and Gupta, S and Moore, DF and Sharabi, Y and (2003) Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease <i>Muscle Nerve<\/i>, 28, pp. 703 - 10.","journal-title":"Muscle Nerve"},{"key":"E00025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.12968\/hosp.2002.63.6.2005","volume":"63","author":"Mehta A","year":"2002","unstructured":"Mehta, A. (2002) Agalsidase alfa: specific treatment for Fabry disease <i>Hosp Med<\/i>, 63, pp. 347 - 50.","journal-title":"Hosp Med"},{"key":"E00026","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2362.2004.01424.x","volume":"34","author":"Beck M","year":"2004","unstructured":"Beck, M and Ricci, R and Widmer, U. (2004) Fabry disease: overall effects of agalsidase alfa treatment <i>Eur J Clin Invest<\/i>, 34, pp. 838 - 44.","journal-title":"Eur J Clin Invest"}],"container-title":["Acta Paediatrica"],"original-title":[],"link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F08035250500275022","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1080\/08035250500275022\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T16:38:20Z","timestamp":1612975100000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1080\/08035250500275022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1,1]]}},"alternative-id":["P6V0M17474N11W71"],"URL":"https:\/\/doi.org\/10.1080\/08035250500275022","relation":{},"ISSN":["0803-5253"],"issn-type":[{"value":"0803-5253","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1,1]]}}}